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Transplant physicians and candidates have become
increasingly aware that donor characteristics signif-
icantly impact liver transplantation outcomes. Al-
though the qualitative effect of individual donor vari-
ables are understood, the quantitative risk associated
with combinations of characteristics are unclear. Us-
ing national data from 1998 to 2002, we developed
a quantitative donor risk index. Cox regression mod-
els identified seven donor characteristics that indepen-
dently predicted significantly increased risk of graft
failure. Donor age over 40 years (and particularly over
60 years), donation after cardiac death (DCD), and
split/partial grafts were strongly associated with graft
failure, while African-American race, less height, cere-
brovascular accident and ‘other’ causes of brain death
were more modestly but still significantly associated
with graft failure. Grafts with an increased donor risk
index have been preferentially transplanted into older
candidates (>50 years of age) with moderate disease
severity (nonstatus 1 with lower model for end-stage
liver disease (MELD) scores) and without hepatitis C.
Quantitative assessment of the risk of donor liver graft
failure using a donor risk index is useful to inform the
process of organ acceptance.
Received 1 August 2005, revised 11 November 2005
and accepted for publication 30 November 2005
Introduction
Increasingly aggressive organ utilization has paralleled the
progressive shortage of donor organs (1). In today’s desper-
ate climate, the opportunity for transplantation presented
by each and every organ of each and every deceased
donor is thoroughly evaluated by organ procurement or-
ganizations and transplant physicians. As the frontiers of
utilization continue to expand previously defined bound-
aries, there is increasing awareness of the potential im-
pact of aggressive utilization practices on graft and pa-
tient outcomes. Analyses that define the effect of specific
donor characteristics on the risk of post-transplant graft
failure have been performed, particularly in the realm of
kidney transplantation. This approach has yielded quanti-
tative descriptions of organ quality, which have lent speci-
ficity and granularity to pre-existing qualitative descriptions.
Currently, the relative risk (RR) of graft failure for every kid-
ney donor as compared to an ‘ideal donor’ can be deter-
mined based upon published analyses of national data (2).
This information, essentially a descriptor of organ quality
based solely upon donor characteristics, can facilitate the
necessary and important discussions between transplant
physicians and candidates at the time of placement on the
waiting list and at the time of a specific opportunity for
kidney transplantation.
We embarked on the current study with the aim of deriv-
ing such descriptors in the setting of liver transplantation.
The value of such information is heightened by the life-
saving and life-threatening potential of every decision to
either accept or reject a particular opportunity for trans-
plantation. For the potential candidate, the model for end-
stage liver disease (MELD) scoring system, based solely
upon liver transplant candidate characteristics, accurately
estimates the risk of death without transplantation (3–5). In
discussing transplant possibilities with candidates, quanti-
tation of the risks associated with specific combinations
of donor characteristics would be valuable. This study ex-
amines putative donor risk factors for graft failure as the




All information regarding donor characteristics and transplant outcomes
were from the Scientific Registry of Transplant Recipients (SRTR), as
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submitted by members of the Organ Procurement and Transplantation Net-
work. This study was approved by HRSA’s SRTR project officer. HRSA has
determined that this study satisfies the criteria for the IRB exemption de-
scribed in the ‘Public Benefit and Service Program’ provisions of 45 CFR
46.101(b) (5) and HRSA Circular 03.
Data from 20 023 transplants, using livers from deceased donors, per-
formed in the United States between January 1, 1998 and December
31, 2002 into adult recipients (≥18 years of age) were used to identify
factors associated with significantly increased risk of graft loss. Multi-
ple organ transplants were excluded. In order to investigate the utiliza-
tion of livers from deceased donors with characteristics associated with
a higher risk of graft loss, data on 9882 deceased donor livers procured
for transplantation between April 1, 2002 and December 31, 2003 were
examined.
Analytical methods
Predictors of time to graft failure were identified using Cox regression mod-
els. Time to graft failure was defined as the period between transplanta-
tion and graft loss secondary to either retransplantation or recipient death,
whichever occurred first. All available post-transplant follow-up data were
used in the analysis (6). Patients were followed for at least 1 year after
transplantation. The median follow-up time was 3 years. Missing values for
covariates in the regression model were handled with multiple imputation
using standard methods available with SAS version 9.1 (SAS Institute, Cary,
NC) and IVEWARE imputation software (University of Michigan–Survey Re-
search Center, Ann Arbor, MI) (7). Donor parameters investigated include
age; sex; race; ethnicity; height; weight; body mass index; cause of death
(COD) (trauma, cerebrovascular accident (CVA), anoxia and other); serum
levels of creatinine, blood urea nitrogen, glutamic oxaloacetic and pyruvic
transaminases (SGOT [AST] and SGPT [ALT]) and total bilirubin; history of
insulin-dependent diabetes mellitus, hypertension, cancer, cigarette, alco-
hol, and intravenous drug use; cytomegalovirus status; hepatitis B core an-
tibody status; hepatitis C virus antibody status; serum sodium >170 mEq/L;
requirement for inotropic agents (dopamine/dobutamine); cardiac arrest af-
ter brain death; administration of anti-convulsants, anti-hypertensive and
vasodilators within 24 h of donor aortic cross-clamp; donation after cardiac
death (DCD) and a split/partial liver graft. The parameter estimates for donor
factors that were identified as significantly associated with increased risk
of graft loss were combined as the foundation for calculating the donor risk
index. The donor risk index can be used to compare the RR of graft loss
for an organ with a specific set of donor and transplant characteristics to a
reference case.
To isolate the impact of donor characteristics on liver allograft outcomes, all
models were adjusted for recipient and transplant factors that may impact
allograft failure. Recipient factors included in all models were age; sex; race;
ethnicity; body mass index; underlying liver disease diagnosis (acute hepatic
necrosis, cholestatic liver disease, noncholestatic liver disease, metabolic
liver disease, malignancy, or other); hepatitis B status; hepatitis C status;
cytomegalovirus status; history of previous liver transplant; history of previ-
ous abdominal surgery; angina pectoris; diabetes mellitus; cerebrovascular
disease; transfusion at time of listing; SGOT (AST); total bilirubin, albumin
and creatinine; dialysis status at time of transplantation; medical condition
(intensive care unit, in hospital, or out of hospital); Status 1 medical ur-
gency designation; requirement for life support; grade III or IV hepatic en-
cephalopathy; requirement of inotropic support; portal vein thrombosis at
time of transplantation and incidental tumor identified during transplanta-
tion. Transplant parameters included in all models were ABO compatibility,
cold ischemia time and origin of the donor organ beyond the recipient’s
listing organ procurement organization (shared organ). All analyses were
performed using SAS version 9.1.
Table 1: Descriptive statistics for selected donor parameters (N =
20 023; 1998–2002)










African American 2337 11.7








Donation after cardiac death 223 1.1
HBcAb positive 988 4.9
HCV positive 360 1.8
Sodium > 170 mEq/L 522 2.6
Mean SD
Height (cm) 171.34 12.4
Results
Donor and recipient characteristics
The distribution of donor and recipient characteristics of in-
terest are displayed in Tables 1 and 2. Approximately 30%
of transplants were performed using livers from donors
greater than 50 years of age. Only 2% were performed us-
ing split or partial livers and 1.1% used DCD livers. The vast
majority of donors (88.2%) died of either trauma or stroke.
Less than 5% of donors were positive for hepatitis B core
antibody and less than 2% were positive for hepatitis C
antibody. Over one-third of transplant recipients (39.2%)
tested positive for hepatitis C and nearly two-thirds (64.4%)
were not hospitalized immediately prior to transplantation.
Risk factors for graft failure
Seven donor characteristics identified as significantly as-
sociated with liver allograft failure are listed in Table 3.
These included three donor demographic characteristics
(age, race and height), three relating to cause and type
of donor death (COD CVA, COD other and DCD) and a
split/partial graft. Compared to a reference group of donors
<40 years of age, increasing age was associated with a
significant monotonic increase in the risk of graft failure.
Donor age over 60 years was the strongest risk factor for
graft failure (RR was 1.53 and 1.65, for donor age 61–70 and
>70, respectively; both p < 0.0001). Livers from African-
American donors had a 19% higher risk of graft failure com-
pared to those from white donors (RR 1.19; p < 0.0001).
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Table 2: Descriptive statistics for selected recipient and trans-
plant parameters (N = 20 023; 1998–2002)










African American 1536 7.7
Other 1201 6.0
White 17 286 86.3
Diagnosis
Fulminant hepatic failure 1611 8.0
Non-cholestatic liver disease 14 039 70.1
Cholestatic liver disease 2291 11.4
Metabolic disease 520 2.6
Malignant neoplasm 613 3.1
Other 949 4.7
Hepatitis C positive 7850 39.2
Medical condition
In ICU 4370 21.8
Hospitalized not in ICU 2761 13.8
Not hospitalized 12 892 64.4
Angina 464 2.3
Cerebrovascular disease 103 0.5
Previous transfusion 6979 34.9
Status 1 1660 8.3
On life support 1883 9.4
Previous liver transplant 1763 8.8
CMV positive 11 670 58.3
Pretransplant malignancy 745 3.7
Tumor found at transplant 769 3.8
Previous abdominal surgery 7365 36.8
Inotropes for BP support 1087 5.4
On dialysis 914 4.6
Portal vein thrombosis 521 2.6
Grade III or IV encephalopathy 5665 28.3
Hepatitis B positive 1390 6.9
Mean SD
Total bilirubin 7.09 9.83
Serum creatinine 1.31 1.08
Serum albumin 2.84 0.77
BMI 28.11 11.51
SGOT/AST 269.87 1000.90
Transplant factor Frequency Percent
ABO compatibility








Cold ischemia time 8.22 3.80
Table 3: Donor factors significantly associated with liver allograft
failure (1998–2002)∗
Donor parameter RR 95% CI p-Value
Age
<40 1.00
40—49 1.17 1.08–1.26 0.0002
50–59 1.32 1.21–1.43 <0.0001
60–69 1.53 1.39–1.68 <0.0001
>70 1.65 1.46–1.87 <0.0001
African-American race (vs White) 1.19 1.10–1.29 <0.0001
Donor height (per 10 cm decrease) 1.07 1.04–1.09 <0.0001
COD = CVA 1.16 1.08–1.24 <0.0001
COD = Other† 1.20 1.03–1.40 0.018
DCD 1.51 1.19–1.91 0.0006
Partial/Split 1.52 1.27 – 1.83 <0.0001
∗Model also adjusted for donor sex, serum sodium >170 mEq/L,
and HBcAb status; recipient age, sex, race, ethnicity, BMI,
hepatitis B status, hepatitis C status, CMV status, previous
liver transplant, previous abdominal surgery, angina, diabetes,
cerebrovascular disease, transfusion at time of listing, SGOT,
total bilirubin, albumin, creatinine, dialysis status at time of
transplantation, medical condition, Status 1, life support, grade III
or IV encephalopathy, inotropic support, portal vein thrombosis,
incidental tumor identified during transplantation, ABO compati-
bility, cold ischemia time, and regional or national sharing.
†Cause of death was not trauma, stroke, or anoxia.
Although two parameters reflecting donor size were as-
sessed, the association of height was stronger than, and
independent of, the association of weight. Compared to
trauma as a cause of death, CVA and other causes of death
(not trauma, CVA or anoxia) were associated with 16% and
20% higher risks of graft failure, respectively (both p <
0.02). A test of the statistical interaction between donor
age and CVA cause of death was not significant. DCD sta-
tus and split/partial grafts were associated with a 51% and
52% higher risk of graft failure (p < 0.001).
Two transplant factors, cold ischemia time and sharing out-
side of the local donor service area, were also found to be
significantly associated with increased risk of graft loss.
These factors were independent; there was no significant
interaction between cold ischemia time and donor loca-
tion. Each additional hour of cold ischemia time was as-
sociated with an additional 1% increased risk of graft loss
(p = 0.008). Compared to grafts transplanted within the
local area, grafts that were transplanted outside the local
area but within the same region had an 11% increase in
risk of graft loss (p = 0.002), while grafts that were trans-
planted beyond the region (nationally shared) had a 28%
increased risk of graft loss (p < 0.0001).
Transplants according to donor risk index
To facilitate the understanding of the risks associated with
combinations of donor factors alone, Table 4 shows the
range of donor risk index associated with specific combi-
nations of donor risk factors, the number of transplants
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Table 4: Calculated donor risk index and 1-year graft survival and
95% confidence interval estimates for specified donor profiles
(1998–2002)
Range of 95% CI for
Donor calculated adjusted 1 year
profile N (%) DRI survival estimates
None
Under 40 6814 (34.0%) Ref. 84.8–86.4
40–49 1174 (5.9%) 1.17 82.9–86.9
50–59 653 (3.3%) 1.32 79.0–84.8
60–69 299 (1.5%) 1.53 77.7–85.9
70+ 140 (0.7%) 1.65 61.3–76.3
Cod-Other or Cod-Stroke or Black
Under 40 2683 (13.4%) 1.16–1.20 81.8–84.6
40–49 2128 (10.6%) 1.35–1.40 79.8–83.1
50–59 2293 (11.5%) 1.52–1.58 77.2–80.5
60–69 1445 (7.2%) 1.77–1.84 73.4–77.8
70+ 655 (3.3%) 1.91–1.99 72.4–78.7
(Cod-Other + Race-Black) or (Cod-Stroke + Race-Black)
Under 40 276 (1.4%) 1.38–1.43 71.7–81.3
40–49 365(1.8%) 1.61–1.67 73.7–82.0
50–59 290 (1.5%) 1.81–1.89 73.7–82.8
60–69 132 (0.7%) 2.11–2.19 63.4–78.4
70+ 58 (<0.5%) 2.27–2.37 71.6–91.0
DCD or partial/split
Under 40 344 (1.7%) 1.51–1.52 75.4–83.8
40–49 34 (<0.5%) 1.76–1.78 45.6–78.0
50–59 17 (<0.5%) 1.98–2.01 73.0–100.0
60–69 6 (<0.5%) 2.30–2.33 33.3–100.0
70+ 3 (<0.5%) 2.49–2.52 23.9–100.0
(DCD or partial/split) + at least one other factor
Under 40 129 (0.6%) 1.74–3.30 64.9–80.5
40–49 51 (<0.5%) 2.03–3.85 60.7–84.7
50–59 20 (<0.5%) 2.29–4.34 49.0–91.5
60–69 14 (<0.5%) 2.66–5.04 46.4–97.0
70+ 0 (0.0%) 2.88–5.45 N/A
performed during the 5-year study period and 95% con-
fidence intervals for the corresponding estimated 1-year
survival. The donor risk indices shown were calculated us-
ing reference values of 8 h for cold ischemia time and lo-
cal procurement for donor location. In Table 5, illustrative
donor and transplant factors are sequentially altered begin-
ning with the ideal organ, a whole liver from a donor with-
Table 5: Specific combinations of donor risk factors and the corresponding donor risk index
Donor factor Reference donor Example 1 Example 2 Example 3 Example 4 Example 5
Age Under 40 64 64 64 25 25
Cause of death Trauma Trauma Stroke Stroke Trauma Trauma
Race White White White White White White
DCD No No No No No Yes
Partial/Split No No No No No No
Height (cm) 170 170 170 170 170 170
Location Local Local Local Local Local Local
Cold time (h) 8 8 8 14 14 14
Donor risk index∗ 1.00 1.53 1.77 1.88 1.06 1.60
∗Calculation: Donor risk index = exp[(0.154 if 40≤ age <50) + (0.274 if 50≤ age <60) + (0.424 if 60≤ age <70) + (0.501 if 70 ≤ age) +
(0.079 if COD = anoxia) + (0.145 if COD = CVA) + (0.184 if COD = other) + (0.176 if race = African American) + (0.126 if race = other) +
(0.411 if DCD) + (0.422 if partial/split) + (0.066 ((170–height)/10)) + (0.105 if regional share) + (0.244 if national share) + (0.010 × cold time)].
out any risk factors for graft failure (donor risk index ≤1.0),
to show the impact of selected factors on the donor risk
index.
Adjusted graft survival according to donor risk
index stratification
Adjusted graft survival rates for various categories of the
donor risk index are displayed in Table 6. The donor risk in-
dex calculation includes not only the seven identified donor
factors but also the two identified transplant factors of re-
gional/national sharing and cold ischemia time since these
two variables are known or estimable at the time of organ
offer. Graft survival differences between grafts with higher
versus lower risk indexes are evident 3 months after trans-
plantation and appear to increase over time. For instance,
the 5.6% survival difference at 3 months for grafts with
a donor risk index ≤1.0 compared to grafts with a risk in-
dex between 1.5 and 1.6 increased to 7.7% at 1 year and
10.6% at 3 years.
Recipient characteristics associated with utilization
of grafts with higher donor risk index
Linear regression was used to examine potential associ-
ations between the calculated donor risk index and var-
ious recipient characteristics. Data from 9153 recipients
of deceased donor livers transplanted between April 1,
2002 and December 31, 2003 were used in the regres-
sion model. Results are shown in Table 7. Compared to
the reference recipient age group of 40–49, older recipi-
ents and the youngest recipients were significantly more
likely to receive a graft associated with a higher donor risk
index. For example, the donor risk index for organs trans-
planted into 60–69-year-old recipients was approximately
0.041 higher than that for organs transplanted into 40–49-
year-old recipients, corresponding to a 4.1% increase in
the risk of graft failure (p < 0.0001). The donor risk index
for livers transplanted into 0–10-year-old recipients was ap-
proximately 0.332 higher than for the reference recipient
age group, corresponding to a 33.2% increase in the risk
of graft failure (p ≤ 0.0001). Higher donor risk index organs
were also transplanted into women and recipients with-
out hepatitis C. Although no differences in donor risk index
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Table 6: Adjusted 3-month, 1-year and 3-year graft survival according to donor risk index as determined
by donor, graft and transplant factors (1998–2002)
Graft survival (95% confidence interval)
Donor risk index N (%) 3 Months 1 Year 3 Years
0.0 < DRI ≤ 1.0 3701 (18.5) 91.9 (91.0–92.7) 87.6 (86.6–88.7) 81.2 (79.9–82.6)
1.0 < DRI ≤1.1 2714 (13.6) 90.3 (89.2–91.4) 85.0 (83.7–86.3) 78.7 (77.1–80.3)
1.1 < DRI ≤ 1.2 2272 (11.4) 89.9 (88.7–91.1) 83.6 (82.1–85.1) 75.3 (73.4–77.3)
1.2 < DRI ≤ 1.3 1873 (9.4) 88.5 (87.1–89.9) 83.2 (81.5–84.8) 75.3 (73.2–77.4)
1.3 < DRI ≤ 1.4 1687 (8.4) 88.8 (87.4–90.3) 82.3 (80.5–84.1) 74.1 (71.8–76.3)
1.4 < DRI ≤ 1.5 1625 (8.1) 86.4 (84.8–88.0) 79.7 (77.8–81.6) 71.1 (68.8–73.4)
1.5 < DRI ≤ 1.6 1446 (7.2) 86.3 (84.5–88.0) 79.9 (77.9–82.0) 70.6 (68.1–73.1)
1.6 < DRI ≤ 1.8 2118 (10.6) 84.4 (82.9–85.9) 76.9 (75.1–78.7) 66.8 (64.7–69.0)
1.8 < DRI ≤ 2.0 1343 (6.7) 83.4 (81.4–85.3) 75.8 (73.6–78.1) 65.6 (62.9–68.4)
2.0 < DRI 1244 (6.2) 80.3 (78.1–82.6) 71.4 (68.8–74.1) 60.0 (56.9–63.2)
emerged by recipient medical condition, there were signif-
icant differences by recipient medical urgency. Grafts with
higher donor risk index were most likely utilized for low
disease severity (MELD score 10–14) recipients and least
likely for Status 1 recipients.
Liver disposition by donor risk index categories
Table 8 shows discard rates for recovered livers from April
1, 2002 to December 31, 2003 by categories of donor
risk index. Increasing donor risk index was associated with
higher discard rates among deceased donor livers procured
for transplant. Livers with a donor risk index >1.5 were dis-
carded more than twice as often as those with a risk index
≤1.1.
Discussion
We have identified seven donor and graft characteristics
that are significantly and independently associated with in-
creased failure of deceased donor liver transplants. It is
deliberate and notable that the factors required to deter-
mine the relative risk associated with a particular graft are
known at the time of organ offer. This enables transplant
physicians to share information regarding the risk posed by
any graft offer in juxtaposition to the candidate’s disease
severity at that moment. Such information can provide a
rational foundation to discuss and decide the acceptability
of any organ offer.
Among the donor and graft characteristics that were sig-
nificantly associated with liver graft failure; age; DCD and
split/partial status dominated over donor race, height and
cause of brain death. The relative risk associated with each
decade of increasing donor age rose steeply, beginning at
40 years. The importance of donor age as a negative factor
is accentuated by the soaring frequency of older donors.
While livers from donors greater than 40 years accounted
for about 13% of adult transplants in 1988, they accounted
for 54% of adult transplants in 2003. Since the strong neg-
ative impact of increased donor age on liver transplant out-
comes has long been recognized (8–12), the dramatic in-
crease in utilization of livers from older donors reflects the
increasing disparity between organ demand and supply.
Similarly, transplantation of split/partial or DCD grafts is
associated with greater than 50% increased risk of graft
failure compared to transplantation of whole or donation
after brain death grafts, respectively. Although DCD and
split/partial status are qualitatively different than the other
donor characteristics, they were included to provide a more
comprehensive description of risk according to donor and
graft characteristics. Currently, split/partial and DCD liver
transplants account for only 2.0% and 1.1% of all trans-
plants, respectively. The numbers of these transplants has
and will likely continue to increase (13). Therefore, risk as-
sessment for these grafts will be increasingly useful for
physician and patient decision making.
There is a substantial body of literature presenting algo-
rithms to assess the risk of graft failure after liver trans-
plantation. While there are some similarities between our
current analysis and previous reports, there are some no-
table differences that warrant discussion. The majority of
published studies have examined donor, recipient and/or
transplant factors (14–22). In contrast, our study focused
on donor characteristics while adjusting for an extensive
list of important recipient and transplant characteristics.
Several donor characteristics previously identified by oth-
ers as risk factors did not achieve significance in our anal-
ysis. These included female sex, obesity, elevated liver
function tests (aminotransferases), hypotension/increased
pressor use and elevated levels of serum sodium. Two
other factors, macrosteatosis and cold ischemia time, have
been strongly associated with transplant outcomes (19,23–
27). The degree of macrosteatosis, which may or may
not be known at the time of organ offer, was not signifi-
cantly associated with graft failure in our study. Estimation
of steatosis using frozen section liver biopsy is both diffi-
cult and subjective (28,29). Moreover, OPTN data regarding
steatosis are recorded in broad ranges and, until recently,
did not differentiate between macro- and micro-steatosis.
Therefore, insufficient data may in part explain the lack of
association between macrosteatosis and graft failure. In
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Table 7: Donor risk index according to recipient characteristics for
transplants between April 2002 and December 2003
Difference 95% Confidence
from limits for donor
Recipient reference
parameter group p-Value Upper Lower
Recipient age
0–10 0.332 <.0001 1.65 1.74
11–17 −0.052 0.024 1.24 1.34
18–39 −0.012 0.362 1.30 1.36
40–49 1.343 Ref.
50–59 0.033 <0.0001 1.36 1.40
60–69 0.041 <0.0001 1.36 1.41
70+ 0.116 <0.0001 1.41 1.52
Race
Black −0.010 0.385 1.35 1.39
White 1.380 Ref.
Other 0.039 0.004 1.39 1.45
Sex
Male −0.041 <.0001 1.35 1.38
Female 1.408 Ref.
Diagnosis
AHN −0.011 0.427 1.34 1.40
Non-cholestatic 1.381 Ref.
liver disease
Cholestatic −0.009 0.437 1.35 1.40
liver disease 1.35 1.40
Metabolic disease −0.023 0.224 1.32 1.40
Malignant neoplasms 0.000 0.990 1.35 1.41
Other 0.023 0.047 1.38 1.43
Hepatitis C
Positive −0.027 0.001 1.35 1.38
Negative 1.391 Ref.
Medical condition
Not in hospital 1.377 Ref.
Missing 0.008 0.894 1.26 1.52
In hospital 0.018 0.069 1.38 1.42
In ICU 0.008 0.536 1.36 1.41
Medical urgency
Status 1 −0.058 0.007 1.29 1.38
MELD <10 1.399 Ref.
MELD 10–14 0.044 0.026 1.40 1.49
MELD 15–19 0.008 0.657 1.37 1.45
MELD 20–24 −0.020 0.256 1.34 1.41
MELD 25–29 −0.031 0.090 1.33 1.40
MELD 30–34 −0.026 0.180 1.33 1.41
MELD ≥35 −0.044 0.027 1.31 1.39
contrast, cold ischemia time, which was associated with
risk of graft failure and which can be reasonably estimated
at the time of organ offer, was included in our donor risk
index along with the information about organ sharing at the
regional or national level.
Our study provides a risk assessment for every potential
liver graft compared to the ideal liver graft (i.e., a whole
organ from a donor less than age 40 with brain death sec-
ondary to trauma or anoxia). While ideal grafts are a rela-
tively homogeneous group, non-ideal grafts are quite het-
erogeneous, spanning a broad continuum of graft failure
risk. The heterogeneity reflects the variable impact of not
only individual donor and recipient risk factors but also the
multitude of possible risk factor combinations presented
by the donor pool. Given prevailing trends, the risk of fail-
ure of the average donor liver will likely continue to in-
crease unless advances in organ preservation, utilization
and/or implantation techniques attenuate the negative im-
pact exerted by one or more risk factors. The age of the
average donor is rising, as is the frequency of DCD and
split or partial liver grafts (13). Nearly one-third of all de-
ceased liver donors in 2003 were over age 50. Over the
past 5 years, the number of split or partial liver grafts has
increased by 35%, and the number of livers from DCD
donors has quadrupled. It is ironic that the majority of liv-
ers that are split (a significant risk factor for graft failure)
come from donors that would have been considered ideal if
transplanted as a whole organ (30–32). However, although
the individual outcomes for adult recipients of split grafts
are inferior to those of whole grafts, splitting improves so-
cietal benefit by increasing both the number of patients
transplanted and the net gain of life years (33).
The characteristics of typical recipients of higher risk grafts
presumably reflect the balanced choice that transplant
physicians have made in an attempt to maximize candidate
benefit. Candidates who are most ill face the greatest risk
of death without transplantation and have the greatest sur-
vival benefit from transplantation (34,35). However, candi-
dates who are most ill may have disproportionately poorer
outcomes with higher risk grafts, although the interaction
between donor quality and recipient disease severity is as
yet incompletely defined. Amin and colleagues published
the results of a Markovian model to elucidate the risk and
benefit considerations for accepting or declining a liver of-
fer according to the organ’s potential for failure and the
candidate’s disease severity, as specified by MELD (36).
Using probabilistic criteria to define an expanded criteria
graft based on primary graft failure risk, they compared im-
mediate transplantation with such livers to delayed trans-
plantation using a ‘standard’ donor organ. Immediate trans-
plantation with grafts bearing as much as a 50% risk of pri-
mary graft failure resulted in higher 1-year survival for any
candidate whose MELD score exceeded 20 compared to
waiting; the magnitude of benefit increased as MELD score
increased. While some of the assumptions of the analysis
may be called into question—including the possibility of
recovery from primary graft failure, the rate of retransplan-
tation for primary graft failure, the lack of consideration of
late graft failure and the availability of a standard criteria
donor liver—the 1-year survival benefit afforded by imme-
diate transplantation using higher risk organs was indeed
striking. To validate the concept of the donor risk index, an
extension of our current work is planned, in which we will
formally examine the interaction between donor risk index
and recipient risk factors, using national data instead of a
modeling approach.
As expected, discard rates for organs with higher donor
risk index are higher than for those with lower risk index.
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Table 8: Disposition of 9882 deceased donor livers recovered for transplant by donor risk index (April
1, 2002 to December 31, 2003)
Donor risk index∗ Recovered, N Transplanted, N (%) Discarded, N (%) p-Value
0.0–1.0 1972 1910 (96.9) 62 (3.1) Ref.
1.0–1.1 1202 1153 (95.9) 49 (4.1) 0.1672
1.1–1.2 1006 943 (93.7) 63 (6.3) <0.0001
1.2–1.3 832 782 (94.0) 50 (6.0) 0.0005
1.3–1.4 876 785 (89.6) 91 (10.4) <0.0001
1.4–1.5 842 762 (90.5) 80 (9.5) <0.0001
1.5–1.6 752 673 (89.5) 79 (10.5) <0.0001
1.6–1.8 1174 1056 (89.9) 118 (10.1) <0.0001
1.8–2.0 722 648 (89.8) 74 (10.2) <0.0001
2.0+ 504 441 (87.5) 63 (12.5) <0.0001
Total 9882 9153 (92.6) 729 (7.4)
∗Donors are considered to be in the local donor service area with 8 h of cold ischemia time, since
these factors are unknown for discarded organs.
However, compared to the discard rate of 38% reported for
procured expanded criteria donor kidneys (2), the discard
rate for higher donor risk index organs in our study was
much more modest, exhibiting an increasing trend from
3.1% for organs procured from donors with a risk index
of 1.0 to a maximum of 12.5% for those procured from
a donor with a risk index of 2.0 or greater. This difference
may in part reflect a greater willingness on the part of trans-
plant physicians and candidates to accept increased risk
from suboptimal donor quality in the face of more immi-
nent considerations of candidate mortality in the absence
of transplantation. Moreover, the intended liver recipient
is almost invariably identified prior to procurement, while
deceased donor kidneys are often procured before a re-
cipient has agreed to accept the organ. Practice patterns
of organ procurement, utilization and discard may shift to-
ward increasing use of higher risk liver grafts as candidates
with higher risk profiles are considered and accepted for
transplantation.
Ultimately, at the time of an organ offer, the decision to ac-
cept either the risk of transplantation or the risk of waiting
rests with transplant physicians and their patients. Mak-
ing this decision rationally, however, requires facts about
the risk posed by the particular graft being offered and the
risk of death from progressive liver disease if the current
offer is declined. Since the quality of the donor organ is
such an important component of this decision, our study
provides an important quantitative assessment of relative
risk for every potential graft, given the characteristics of
the intended recipient, based upon donor and graft char-
acteristics available at the time the organ is offered. This
information is necessary to inform discussions of organ
acceptance, both in general terms with patients and their
families, and at the time an offer is made.
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